Back to results

Division of Clinical Pharmacology

Determinants and consequences of the pharmacokinetics of rifampicin, isoniazid, pyrazinamide and ethambutol in a cohort of tuberculosis patients

Abstract

dc:description.abstract

A prospectlve pharmacokinetic study was conducted amongst a cohort of 142 patients with tuberculosis (TB) susceptible to rifampicin and isoniazid at Brewelsleloof Hospital, Worcester, in the Western Cape.

Degree

thesis:*
Grantor dc:publisher.institution
Division of Clinical Pharmacology
Year dc:date.issued
2004

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • McIlleron, Helen
Advisors dc:contributor.advisor
  • Folb, Peter I
  • Little, Francesca
  • Smith, Pete

Rights

Language dc:language.iso
eng

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/11427/3290
OAI identifier oai:identifier
oai:open.uct.ac.za:11427/3290

Chain of custody

source
Harvested from
University of Cape Town
Base URL
open.uct.ac.za/oai/request
Last updated
2026-07-22
Source record
OAI-PMH GetRecord
related terms
citation

McIlleron, Helen. Determinants and consequences of the pharmacokinetics of rifampicin, isoniazid, pyrazinamide and ethambutol in a cohort of tuberculosis patients. Division of Clinical Pharmacology, 2004. http://hdl.handle.net/11427/3290